Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Moorhead

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Blood|March 21, 2014
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myelomaJoaquin Martinez-Lopez, Juan J Lahuerta, François Pepin, et al.
Genome Research|February 3, 2005
Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assayPaul Hardenbol, Fuli Yu, John Belmont, et al.
Nature|March 23, 2017
Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigensMichael S Khodadoust, Niclas Olsson, Lisa E Wagar, et al.
Haematologica|May 20, 2017
The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtypeCarolina Schinke, Antje Hoering, Hongwei Wang, et al.
Nature|July 30, 2010
Diverse somatic mutation patterns and pathway alterations in human cancersZhengyan Kan, Bijay S Jaiswal, Jeremy Stinson, et al.
Blood|September 26, 2018
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myelomaAurore Perrot, Valerie Lauwers-Cances, Jill Corre, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Blood|March 21, 2014
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myelomaJoaquin Martinez-Lopez, Juan J Lahuerta, François Pepin, et al.
Genome Research|February 3, 2005
Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assayPaul Hardenbol, Fuli Yu, John Belmont, et al.
Nature|March 23, 2017
Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigensMichael S Khodadoust, Niclas Olsson, Lisa E Wagar, et al.
Haematologica|May 20, 2017
The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtypeCarolina Schinke, Antje Hoering, Hongwei Wang, et al.
Nature|July 30, 2010
Diverse somatic mutation patterns and pathway alterations in human cancersZhengyan Kan, Bijay S Jaiswal, Jeremy Stinson, et al.
Blood|September 26, 2018
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myelomaAurore Perrot, Valerie Lauwers-Cances, Jill Corre, et al.
Pageof 3